GB202106372D0 - Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana-4 and other notch inhibitors. - Google Patents

Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana-4 and other notch inhibitors.

Info

Publication number
GB202106372D0
GB202106372D0 GBGB2106372.2A GB202106372A GB202106372D0 GB 202106372 D0 GB202106372 D0 GB 202106372D0 GB 202106372 A GB202106372 A GB 202106372A GB 202106372 D0 GB202106372 D0 GB 202106372D0
Authority
GB
United Kingdom
Prior art keywords
notch
syntana
aid
selection
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2106372.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anastasis Ngs
Original Assignee
Anastasis Ngs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anastasis Ngs filed Critical Anastasis Ngs
Priority to GBGB2106372.2A priority Critical patent/GB202106372D0/en
Publication of GB202106372D0 publication Critical patent/GB202106372D0/en
Ceased legal-status Critical Current

Links

GBGB2106372.2A 2021-05-04 2021-05-04 Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana-4 and other notch inhibitors. Ceased GB202106372D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2106372.2A GB202106372D0 (en) 2021-05-04 2021-05-04 Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana-4 and other notch inhibitors.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2106372.2A GB202106372D0 (en) 2021-05-04 2021-05-04 Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana-4 and other notch inhibitors.

Publications (1)

Publication Number Publication Date
GB202106372D0 true GB202106372D0 (en) 2021-06-16

Family

ID=76300980

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2106372.2A Ceased GB202106372D0 (en) 2021-05-04 2021-05-04 Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana-4 and other notch inhibitors.

Country Status (1)

Country Link
GB (1) GB202106372D0 (en)

Similar Documents

Publication Publication Date Title
EP3614940A4 (en) Systems and methods for locating blood vessels in the treatment of rhinitis
IL272948B1 (en) Enpp1 inhibitors and their use for the treatment of cancer
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
EP4253412A3 (en) Inhibition of cytokine-induced sh2 protein in nk cells
SG10201908697XA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
NO20084341L (en) Use of DPP-IV inhibitors
PH12016500270A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases
WO2014138429A3 (en) Peptidomimetic macrocycles and use thereof in regulating hif1alpha
EP3487492A4 (en) Use of eribulin and histone deacetylase inhibitors in the treatment of cancer
EP3525791A4 (en) Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
EP3604529A4 (en) Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome
ZA201903828B (en) Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases
MX2022014713A (en) Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation.
IL275132A (en) C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain
AU2017258649A1 (en) Covalent BTK inhibitors and uses thereof
WO2015156674A3 (en) Method for treating cancer
GB202106372D0 (en) Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana-4 and other notch inhibitors.
PT3937949T (en) Phytoecdysones and the derivatives thereof for use in the treatment of impaired lung function
SG11202002494WA (en) Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
GB201721222D0 (en) Detection of notch mutations as an aid in the selection of eligible patients for treatment with syntana -4 and other notch inhibitors
EP4067504A4 (en) Use of synaptotagmin-7 in the diagnosis and treatment of bipolar disorder
MX2022004259A (en) Mek inhibitors for the treatment of hantavirus infections.
IL282718A (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
EP4054624A4 (en) Mycobacterial compositions and biomarkers for use in treatment and monitoring of therapeutic responsiveness
EP3992617A4 (en) Concentration calculation device and blood treatment system

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)